03/25
Headlines

Idera Pharmaceuticals

Traders Are Watching: Frontier Communications Corporation (NASDAQ:FTR), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), Microsemi Corporation (NASDAQ:MSCC), Allegion plc (NASDAQ:ALLE), OraSure Technologies, Inc. (NASDAQ:OSUR)

Chris Lewis03 mins

Frontier Communications Corporation (NASDAQ:FTR) reported third-quarter revenue of USD 1.141 billion, down 4 percent year-over-year. Residential revenue rose 0.2 percent sequentially to USD 498.0 million, and total business revenue of USD 518.6 million was up 0.5 percent sequentially. Network access expenses rose, while other operating expenses and depreciation and amortisation declined in the quarter. Operating…

Read More

Best Stocks: Dollar Tree (NASDAQ:DLTR), Cambrex (NYSE:CBM), Union Bankshares Corporation (NASDAQ:UBSH), ShoreTel, Inc. (NASDAQ:SHOR), Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)

Kristen Barton03 mins

On 29 JULY Dollar Tree, Inc. (NASDAQ:DLTR) said it agreed to buy Family Dollar Stores Inc.  for about $8.5 billion, creating a sprawling discount chain with $18 billion in sales and more locations than any other retailer in the U.S. Dollar Tree, Inc. (NASDAQ:DLTR) belongs to Services sector. Its net profit margin is 7.50% and weekly…

Read More

Bullish Stocks At NASDAQ: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Scientific Games Corp (NASDAQ:SGMS), Origin Agritech (NASDAQ:SEED), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Mark Doerr02 mins

Idera Pharmaceuticals Inc (NASDAQ:IDRA) issued its quarterly earnings data on Tuesday. The company reported ($0.12) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.08) by $0.04, American Banking News reports. Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock performance was 11.02% in last session and finished the day at $2.82. Traded volume was 4,339,672 shares…

Read More

NASDAQ Active Stocks: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Amarin Corporation plc (ADR) (NASDAQ:AMRN), Depomed Inc (NASDAQ:DEPO)

Mark Doerr02 mins

Idera Pharmaceuticals Inc (NASDAQ:IDRA) announce plans to initiate clinical development of its lead compound, IMO-8400, for the treatment of patients with polymyositis and patients with dermatomyositis, two orphan autoimmune diseases with high unmet clinical needs. Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock performance was 1.23% in last session and finished the day at $ 2.47. Traded volume…

Read More

Bearish Stocks: MannKind Corporation (NASDAQ:MNKD), Prana Biotechnology Limited (NASDAQ:PRAN), Oi SA (ADR) (NYSE:OIBR), Idera Pharmaceuticals (NASDAQ:IDRA)

Colin Pettis03 mins

Shares of MannKind Corp. (NASDAQ:MNKD) fall as much as 27.105% prior to Tuesday’s Endocrinologic and Metabolic Drugs Advisory Committee Meeting. MannKind Corporation (NASDAQ:MNKD) stock performance was -16.77% in last session and finished the day at $4.02. Traded volume was 30,207,668 million shares in the last session and the average volume of the stock remained 7.92…

Read More